The company utilizes third-party manufacturers with limited facilities and experience to produce its product candidates, which may affect the timeliness and quality of production. These manufacturers also serve other clients and priorities, potentially impacting their performance. Contract manufacturers are subject to periodic inspections by the FDA, DEA, and other agencies to ensure compliance with current Good Manufacturing Practices (cGMPs) and regulations; however, the company has limited control over their compliance beyond contractual obligations. Non-compliance by these manufacturers could result in product recalls, production stoppages, and supply disruptions. Changing manufacturers requires regulatory approval, testing, and inspections, which may cause delays. The limited number of potential manufacturers further complicates replacement efforts. Additionally, the FDA and other regulatory bodies enforce extensive regulations on clinical development, manufacturing, and marketing of products, necessitating rigorous testing and approval processes prior to marketing in the United States.
Journey Medical's Comment on Supply Chain
The company utilizes third-party manufacturers with limited facilities and experience to produce its product candidates, which may affect the timeliness and quality of production. These manufacturers also serve other clients and priorities, potentially impacting their performance. Contract manufacturers are subject to periodic inspections by the FDA, DEA, and other agencies to ensure compliance with current Good Manufacturing Practices (cGMPs) and regulations; however, the company has limited control over their compliance beyond contractual obligations. Non-compliance by these manufacturers could result in product recalls, production stoppages, and supply disruptions. Changing manufacturers requires regulatory approval, testing, and inspections, which may cause delays. The limited number of potential manufacturers further complicates replacement efforts. Additionally, the FDA and other regulatory bodies enforce extensive regulations on clinical development, manufacturing, and marketing of products, necessitating rigorous testing and approval processes prior to marketing in the United States.
Sources:
Journey Medical Corp's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Journey Medical Corp’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
